Comparing dapagliflozin and metformin for PCOS-related infertility
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study compares two medicines—dapagliflozin and metformin—to see which works better for women with PCOS who are trying to get pregnant. Both drugs may help improve hormone balance and ovulation, but they work differently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old.
- You have been diagnosed with polycystic ovary syndrome (PCOS).
- You are having trouble getting pregnant (infertility).
- You do not have diabetes, liver or kidney disease, cancer, or a recent heart attack or stroke.
- You have not used hormonal birth control, weight-loss medications, or certain diabetes drugs in the past 8 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medicines, vildagliptin and metformin, to see which is better at helping women with polycystic ovary syndrome (PCOS) get pregnant. It is for women who are struggling to conceive and do not have diabetes.
This trial compares two medicines, vildagliptin and metformin, to see which works better for women with Polycystic Ovary Syndrome (PCOS). The goal is to find a safe and effective treatment that may help manage PCOS symptoms.
This study tests whether two natural supplements—alpha lipoic acid and myo-inositol—can help manage PCOS symptoms in women without diabetes. The trial aims to see if this combination improves insulin sensitivity and ovulation.
This study tests whether a class of diabetes drugs called GLP-1 receptor agonists can improve fertility in overweight women with polycystic ovary syndrome who want to conceive. These drugs help with weight and blood sugar, which may improve ovulation and pregnancy chances.
This trial tests whether a class of drugs called GLP-1 receptor agonists (often used for diabetes and weight loss) can improve pregnancy outcomes in women with polycystic ovary syndrome (PCOS) who are overweight or obese. If you have PCOS and a BMI between 28 and 35, you may be eligible to participate.
This study looks at whether taking a medicine called Glucophage (also known as metformin) during pregnancy can improve pregnancy outcomes for women who have polycystic ovary syndrome (PCOS). The researchers will compare the results of women who take Glucophage with those who do not.
Hear when a new Poly Cystic Ovary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.